{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:24Z","timestamp":1791225984415,"version":"4.1.0"},"reference-count":250,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.addr.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,12,14]],"date-time":"2008-12-14T09:29:14Z","timestamp":1229246954000},"page":"140-157","source":"Crossref","is-referenced-by-count":232,"title":["Nanoparticles for nasal vaccination"],"prefix":"10.1016","volume":"61","author":[{"given":"Noemi","family":"Csaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Garcia-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1075173","article-title":"Medicine. The intangible value of vaccination","volume":"297","author":"Rappuoli","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.09.005_bib2","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1126\/science.1086916","article-title":"Medicine. The need for a global HIV vaccine enterprise","volume":"300","author":"Klausner","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.09.005_bib3","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine-recommendations of the advisory commitee on immunization practices (acip)","volume":"56","author":"Markowitz","year":"2007","journal-title":"Morb. Mort. Wkly. Rep."},{"key":"10.1016\/j.addr.2008.09.005_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002826-200601000-00008","article-title":"Immunotherapy for alzheimer's disease and other dementias","volume":"29","author":"Boche","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.addr.2008.09.005_bib5","first-page":"17","article-title":"M cells in antigen sampling in mucosal tissues","volume":"236","author":"Neutra","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib6","unstructured":"Medimmune, 2007, http:\/\/www.medimmune.com\/."},{"key":"10.1016\/j.addr.2008.09.005_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2005.09.014","article-title":"Aids vaccine: intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres","volume":"109","author":"Akagi","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jmv.10279","article-title":"Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice","volume":"69","author":"Akagi","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2008.09.005_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.addr.2004.10.001","article-title":"Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems","volume":"57","author":"Friede","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib12","doi-asserted-by":"crossref","first-page":"e2954","DOI":"10.1371\/journal.pone.0002954","article-title":"Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine","volume":"3","author":"Makidon","year":"2008","journal-title":"Plos One"},{"key":"10.1016\/j.addr.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0264-410X(00)00358-3","article-title":"Ensuring vaccine safety in immunization programmes \u2014 a WHO perspective","volume":"19","author":"Jodar","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib14","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(03)13494-0","article-title":"Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries","volume":"361","author":"Jodar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1126\/science.305.5681.147","article-title":"The global vaccination gap","volume":"305","author":"Mahmoud","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.09.005_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(97)00058-6","article-title":"Anatomy, physiology and function of the nasal cavities in health and disease","volume":"29","author":"Dahl","year":"1998","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357011775145","article-title":"The biopharmaceutical aspects of nasal mucoadhesive drug delivery","volume":"53","author":"Ugwoke","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/smim.2000.0253","article-title":"Localization dose and time of antigens determine immune reactivity","volume":"12","author":"Zinkernagel","year":"2000","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1211\/0022357021778448","article-title":"Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers","volume":"54","author":"Perez","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1023\/A:1011922819926","article-title":"Stealth PLA-PEG nanoparticles as protein carriers for nasal administration","volume":"15","author":"Tobio","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/17425247.3.4.463","article-title":"The performance of nanocarriers for transmucosal drug delivery","volume":"3","author":"Csaba","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2008.09.005_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00149-1","article-title":"Exploiting M cells for drug and vaccine delivery","volume":"50","author":"Clark","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib24","series-title":"Anatomy and physiology","author":"Guyton","year":"1985"},{"key":"10.1016\/j.addr.2008.09.005_bib25","first-page":"445","article-title":"A reappraisal of the ultrastructure of the human respiratory nasal mucosa","volume":"124","author":"Busuttil","year":"1977","journal-title":"J. Anat."},{"key":"10.1016\/j.addr.2008.09.005_bib26","first-page":"612","article-title":"Human respiratory mucus","volume":"134","author":"Kaliner","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.addr.2008.09.005_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0169-409X(93)90014-U","article-title":"Mucociliary clearance and drug delivery via the respiratory tract","volume":"11","author":"Lansley","year":"1993","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10611869808997870","article-title":"Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?","volume":"5","author":"Mathison","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2008.09.005_bib29","first-page":"1","article-title":"Nose to brain delivery: approaches for drug deposition in human olfactory epithelium","volume":"5","author":"Dhanda","year":"2005","journal-title":"Drug Deliv. Techn."},{"key":"10.1016\/j.addr.2008.09.005_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2008.09.005_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2249.2003.02311.x","article-title":"Nasal-associated lymphoid tissue (NALT): frequency and localization in young children","volume":"134","author":"Debertin","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2249.2006.03190.x","article-title":"Coincidence of different structures of mucosa-associated lymphoid tissue (MALT) in the respiratory tract of children: no indications for enhanced mucosal immunostimulation in sudden infant death syndrome (SIDS)","volume":"146","author":"Debertin","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0030-6665(20)31638-8","article-title":"The embryogenesis and anatomy of Waldeyer's ring","volume":"20","author":"Goeringer","year":"1987","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.addr.2008.09.005_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0105-2896.2005.00299.x","article-title":"Bronchus- and nasal-associated lymphoid tissues","volume":"206","author":"Bienenstock","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.immunol.25.022106.141634","article-title":"Mucosal dendritic cells","volume":"25","author":"Iwasaki","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.addr.2004.09.008","article-title":"Immunity in response to particulate antigen-delivery systems","volume":"57","author":"Storni","year":"2005","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.micro.51.1.311","article-title":"Interaction of antigens and antibodies at mucosal surfaces","volume":"51","author":"Lamm","year":"1997","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.addr.2008.09.005_bib39","first-page":"33","article-title":"Dendritic cells and Langerhans cells in the uptake of mucosal antigens","volume":"236","author":"MacPherson","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1176","article-title":"Recent advances in the discovery and delivery of vaccine adjuvants","volume":"2","author":"O'Hagan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2008.09.005_bib42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1462-5822.2003.00318.x","article-title":"Innate immunity and biodefence vaccines","volume":"5","author":"Valiante","year":"2003","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.addr.2008.09.005_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nbt0307-303","article-title":"Toll-free vaccines?","volume":"25","author":"Krieg","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2008.09.005_bib44","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1084\/jem.185.12.2157","article-title":"On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly\/aly) and spleenless (hox11(\u2212)\/\u2212) mutant mice","volume":"185","author":"Karrer","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2008.09.005_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib46","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.4049\/jimmunol.164.12.6296","article-title":"Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design","volume":"164","author":"Ochsenbein","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/14760584.4.2.185","article-title":"Nanoparticles as carriers for nasal vaccine delivery","volume":"4","author":"Koping-Hoggard","year":"2005","journal-title":"Expet. Rev. Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2008.09.005_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0006-3495(94)80802-1","article-title":"Antibody diffusion in human cervical mucus","volume":"66","author":"Saltzman","year":"1994","journal-title":"Biophys. J."},{"key":"10.1016\/j.addr.2008.09.005_bib50","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/1520-6017(200007)89:7<835::AID-JPS1>3.0.CO;2-6","article-title":"The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers","volume":"89","author":"Sanders","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib51","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.09.005_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2273.2003.00707.x","article-title":"The impact of expiration on particle deposition within the nasal cavity","volume":"28","author":"Wiesmiller","year":"2003","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.addr.2008.09.005_bib53","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1019854327540","article-title":"Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport","volume":"19","author":"Behrens","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2004.04.026","article-title":"Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density","volume":"98","author":"Vila","year":"2004","journal-title":"J. Control. Release"},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2008.09.005_bib55","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0169-409X(01)00184-3","article-title":"Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas","volume":"50","author":"Florence","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of bsa loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(01)00486-2","article-title":"Design of biodegradable particles for protein delivery","volume":"78","author":"Vila","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/jappl.2001.91.1.211","article-title":"Further analysis of transcytosis of free polypeptides and polypeptide-coated nanobeads in rabbit nasal mucosa","volume":"91","author":"Cremaschi","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2008.09.005_bib59","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1021\/ma060230j","article-title":"Formation of new glucomannan\u2013chitosan nanoparticles and study of their ability to associate and deliver proteins","volume":"39","author":"Alonso-Sande","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2008.09.005_bib60","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1021\/la801085d","article-title":"Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells","volume":"24","author":"Wattendorf","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2008.09.005_bib61","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1128\/JVI.73.9.7780-7786.1999","article-title":"Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers","volume":"73","author":"Gluck","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2008.09.005_bib62","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.188.11.2075","article-title":"Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant","volume":"188","author":"Pulendran","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2008.09.005_bib63","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.4049\/jimmunol.169.7.3837","article-title":"DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals","volume":"169","author":"Mwangi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/203733a0","article-title":"Immunological paralysis induced in adult rabbits by small amounts of a protein antigen","volume":"203","author":"Dresser","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib65","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0169-409X(02)00073-X","article-title":"Immunological aspects of controlled antigen delivery","volume":"54","author":"Lofthouse","year":"2002","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib66","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.95.16.9477","article-title":"T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles","volume":"95","author":"Fehr","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.09.005_bib67","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/nl050541s","article-title":"Nanosphere induced gene expression in human dendritic cells","volume":"5","author":"Matsusaki","year":"2005","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2008.09.005_bib68","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll-like receptors in the induction of the innate immune response","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0162-3109(00)80303-3","article-title":"Complement and innate immunity","volume":"49","author":"Song","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.addr.2008.09.005_bib70","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.4049\/jimmunol.174.12.8154","article-title":"Mannose-containing molecular patterns are strong inducers of cyclooxygenase-2 expression and prostaglandin E2 production in human macrophages","volume":"174","author":"Fernandez","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib71","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.gene.6363791","article-title":"IFNs activate Toll-like receptor gene expression in viral infections","volume":"2","author":"Miettinen","year":"2001","journal-title":"Genes Immun."},{"key":"10.1016\/j.addr.2008.09.005_bib72","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.4049\/jimmunol.166.12.7128","article-title":"An essential role of the NF-kappa B\/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells","volume":"166","author":"Li","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib73","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib74","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1126\/science.1135299","article-title":"Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling","volume":"314","author":"Gavin","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.09.005_bib75","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature04875","article-title":"Immunology: Toll-like receptors and antibody responses","volume":"441","author":"Nemazee","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib76","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib77","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib78","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib79","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1128\/IAI.69.10.6123-6130.2001","article-title":"Th1 adjuvant N-acetyl-d-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (mpb-59) in interleukin-10-knockout and wild-type mice","volume":"69","author":"Shibata","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2008.09.005_bib80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The th1\/th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.addr.2008.09.005_bib81","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1073\/pnas.96.3.1036","article-title":"Distinct dendritic cell subsets differentially regulate the class of immune response in vivo","volume":"96","author":"Pulendran","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.09.005_bib82","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1471-4906(01)01975-5","article-title":"Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways","volume":"22","author":"Jankovic","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/cyto.1996.0139","article-title":"Immunomodulation by quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response","volume":"9","author":"Villacres-Eriksson","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.addr.2008.09.005_bib84","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y","article-title":"Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming","volume":"30","author":"Gagliardi","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.09.005_bib86","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ni736","article-title":"Mouse type I IFN-producing cells are immature apcs with plasmacytoid morphology","volume":"2","author":"Asselin-Paturel","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib87","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","article-title":"Vaccine adjuvants revisited","volume":"25","author":"Aguilar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib88","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","article-title":"Nanotechnology in vaccine delivery","volume":"60","author":"Peek","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib89","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/308457a0","article-title":"ISCOM, a novel structure for antigenic presentation of membrane-proteins from enveloped viruses","volume":"308","author":"Morein","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib90","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0889-1605(89)90018-9","article-title":"Quaternary structure of the immunostimulating complex (ISCOM)","volume":"102","author":"Ozel","year":"1989","journal-title":"J. Ultrastruct. Mol. Struct. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib91","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.addr.2004.09.006","article-title":"ISCOMATRIX\u00ae adjuvant for antigen delivery","volume":"57","author":"Pearse","year":"2005","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib92","first-page":"1","article-title":"Saponins as vaccine adjuvants","volume":"13","author":"Kensil","year":"1996","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.addr.2008.09.005_bib93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(01)00165-X","article-title":"Immunostimulating complexes (ISCOMS) for nasal vaccination","volume":"51","author":"Hu","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib94","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/S0264-410X(01)00142-6","article-title":"Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant qs-21","volume":"19","author":"Waite","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib95","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/S0264-410X(00)00497-7","article-title":"Immune responses to ISCOM\u00ae formulations in animal and primate models","volume":"19","author":"Sjolander","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib96","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0008-8749(90)90111-4","article-title":"Characterization of immunomodulatory properties and accessory cell-function of small intestinal epithelial-cells","volume":"127","author":"Santos","year":"1990","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1348-0421.1992.tb01657.x","article-title":"Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leukocytes","volume":"36","author":"Watson","year":"1992","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2249.1993.tb06507.x","article-title":"The induction of cell-associated and secreted IL-1 by ISCOMs, matrix or micelles in murine splenic cells","volume":"93","author":"Villacres-Eriksson","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib99","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1158\/1078-0432.CCR-03-0245","article-title":"Ny-eso-1 protein formulated in iscomatrix adjuvant is a potent anticancer vaccine inducing both humoral and CD8(+) T-cell-mediated immunity and protection against ny-eso-1(+) tumors","volume":"10","author":"Maraskovsky","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2008.09.005_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/cimm.1997.1088","article-title":"ISCOMs containing purified quillaja saponins upregulate both Th1-like and Th2-like immune responses","volume":"177","author":"Sjolander","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib101","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/eji.1830251019","article-title":"Induction of Th1 and Th2 CD4(+) T-cell responses by oral or parenteral immunization with ISCOMs","volume":"25","author":"Maloy","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib102","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/JVI.73.2.930-938.1999","article-title":"Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice","volume":"73","author":"Brennan","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2008.09.005_bib103","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-3083.1988.tb02397.x","article-title":"Cellular immune-responses in the murine lung to local immunization with influenza-a virus glycoproteins in micelles and immunostimulatory complexes (ISCOMs)","volume":"27","author":"Jones","year":"1988","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib104","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2249.1990.tb05467.x","article-title":"An experimental influenza subunit vaccine (ISCOM) \u2014 induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration","volume":"82","author":"Lovgren","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2249.1998.00650.x","article-title":"The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses","volume":"113","author":"Hu","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib106","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2567.1998.00441.x","article-title":"Intranasal immunization of mice with herpes simplex virus type 2 recombinant gd2: the effect of adjuvants on mucosal and serum antibody responses","volume":"93","author":"Ugozzoli","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2008.09.005_bib107","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.167.6.3398","article-title":"Cta1-dd-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen","volume":"167","author":"Mowat","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib108","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0264-410X(02)00545-5","article-title":"Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine","volume":"21","author":"Coulter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib109","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1016\/j.vaccine.2008.05.004","article-title":"Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against helicobacter pylori","volume":"26","author":"Skene","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib110","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1016\/j.vaccine.2008.06.024","article-title":"In vivo activity of cationic immune stimulating complexes (PLUSCOMs)","volume":"26","author":"McBurney","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib111","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/S0264-410X(99)00052-3","article-title":"Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rctb in local and remote mucosal secretions","volume":"17","author":"Ekstrom","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib112","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/S0264-410X(01)00110-4","article-title":"Intranasal immunisation with influenza-iscom induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses","volume":"19","author":"Sjolander","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib113","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0065-3519(99)80030-5","article-title":"ISCOM: a delivery system for neonates and for mucosal administration","volume":"41","author":"Morein","year":"1999","journal-title":"Adv. Vet. Med."},{"key":"10.1016\/j.addr.2008.09.005_bib114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0264-410X(92)90026-G","article-title":"Initiation of cytotoxic T-cell response and protection of BALB\/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine","volume":"10","author":"Trudel","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-2427(98)00171-8","article-title":"A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with echinococcus granulosus surface antigens ISCOMs","volume":"65","author":"Carol","year":"1998","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.addr.2008.09.005_bib116","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/0264-410X(93)90099-J","article-title":"Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and fca: Role in protection against influenza a in mice","volume":"11","author":"Ben Ahmeida","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib117","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/jmv.20860","article-title":"Comparison of intranasal with targeted lymph node immunization using pr8-flu ISCOM adjuvanted HIV antigens in macaques","volume":"79","author":"Koopman","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2008.09.005_bib118","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.166.5.3589","article-title":"Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine","volume":"166","author":"Polakos","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib119","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1016\/S0264-410X(01)00243-2","article-title":"Cytotoxic T cell polyepitope vaccines delivered by ISCOMs","volume":"19","author":"Le","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vetimm.2005.06.009","article-title":"The use of a systemic prime\/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses","volume":"108","author":"Crouch","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.addr.2008.09.005_bib121","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.01290-06","article-title":"The combined cta1-dd\/iscoms vector is an effective intranasal adjuvant for boosting prior mycobacterium bovis BCG immunity to mycobacterium tuberculosis","volume":"75","author":"Andersen","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2008.09.005_bib122","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0264-410X(98)00112-1","article-title":"Vaccine strategies to overcome maternal antibody mediated inhibition of measles vaccine","volume":"16","author":"Osterhaus","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib123","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.vaccine.2004.07.006","article-title":"Bovine respiratory syncytial virus ISCOMs-protection in the presence of maternal antibodies","volume":"23","author":"Hagglund","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib124","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1461-5347(98)00007-8","article-title":"Liposomes: Quo vadis?","volume":"1","author":"Storm","year":"1998","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.addr.2008.09.005_bib125","article-title":"Liposomes as carriers of enzymes or drugs \u2014 new approach to treatment of storage diseases","volume":"124","author":"Gregoriades","year":"1971","journal-title":"Biochem. J."},{"key":"10.1016\/j.addr.2008.09.005_bib126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/252252a0","article-title":"Liposomes as immunological adjuvants","volume":"252","author":"Allison","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.addr.2008.09.005_bib127","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/S0264-410X(03)00457-2","article-title":"Mucosal antibody response induced with a nasal virosome-based influenza vaccine","volume":"21","author":"Durrer","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib128","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0264-410X(02)00540-6","article-title":"Liposomes and iscoms","volume":"21","author":"Kersten","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-5793(97)00493-6","article-title":"Liposome-mediated peptide loading of mhc-dr molecules in vivo","volume":"409","author":"tHart","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2008.09.005_bib130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/JVI.64.2.680-685.1990","article-title":"Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein-d of herpes-simplex virus \u2014 implications for subunit vaccines","volume":"64","author":"Brynestad","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2008.09.005_bib131","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/0264-410X(95)00037-2","article-title":"Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody-responses against inactivated measles-virus administered intranasally to mice","volume":"13","author":"Dehaan","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib132","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0008-8749(91)90362-F","article-title":"Liposome adjuvanticity \u2014 influence of dose and protein\u2013lipid ratio on the humoral response to encapsulated and surface-linked antigen","volume":"136","author":"Therien","year":"1991","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib133","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2172-9-38","article-title":"Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes","volume":"9","author":"Rosada","year":"2008","journal-title":"BMC Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib134","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.vaccine.2008.02.058","article-title":"Surface modified liposomes for nasal delivery of DNA vaccine","volume":"26","author":"Khatri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib135","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1084\/jem.175.2.609","article-title":"Soluble-proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic lymphocyte-T responses invitro","volume":"175","author":"Nair","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2008.09.005_bib136","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-302X.1997.tb00734.x","article-title":"Nasal immunization of humans with dehydrated liposomes containing streptococcus mutans antigen","volume":"12","author":"Childers","year":"1997","journal-title":"Oral Microbiol. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib137","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0264-410X(96)00278-2","article-title":"Mucosal immunization with DNA-liposome complexes","volume":"15","author":"Klavinskis","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib138","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/107999099313893","article-title":"Induction of mucosal immune responses by administration of liposome\u2013antigen formulations and interleukin-12","volume":"19","author":"Baca-Estrada","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.addr.2008.09.005_bib139","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/IAI.67.2.618-623.1999","article-title":"A controlled clinical study of the effect of nasal immunization with a streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses","volume":"67","author":"Childers","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2008.09.005_bib140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11095-005-9078-7","article-title":"Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome\u2013protamine\u2013DNA particles","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib141","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejpb.2006.05.005","article-title":"Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN","volume":"64","author":"Tafaghodi","year":"2006","journal-title":"Eur. J. Pharm. Biopharm. Biopharm."},{"key":"10.1016\/j.addr.2008.09.005_bib142","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.160.4.2000","article-title":"HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160","volume":"160","author":"Vancott","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib143","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0264-410X(00)00019-0","article-title":"Intranasal immunization with liposome-formulated yersinia pestis vaccine enhances mucosal immune responses","volume":"18","author":"Baca-Estrada","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib144","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1034\/j.1399-302X.2003.00067.x","article-title":"Intranasal immunization of humans with streptococcus mutans antigens","volume":"18","author":"Li","year":"2003","journal-title":"Oral Microbiol. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4049\/jimmunol.170.1.495","article-title":"HIV mucosal vaccine: Nasal immunization with gp160-encapsulated hemagglutinating virus of japan-liposome induces antigen-specific CTLs and neutralizing antibody responses","volume":"170","author":"Sakaue","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib146","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.vaccine.2004.03.047","article-title":"Intranasal immunisation of mice with liposomes containing recombinant meningococcal opab and opaj proteins","volume":"22","author":"de Jonge","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib147","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1016\/j.vaccine.2005.12.017","article-title":"A new intranasal influenza vaccine based on a novel polycationic lipid\u2013ceramide carbamoyl\u2013spermine (ccs) i. Immunogenicity and efficacy studies in mice","volume":"24","author":"Joseph","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib148","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/IAI.68.10.5509-5516.2000","article-title":"Adjuvant activity of monophosphoryl lipid a for nasal and oral immunization with soluble or liposome-associated antigen","volume":"68","author":"Childers","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2008.09.005_bib149","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0264-410X(95)93129-W","article-title":"Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes","volume":"13","author":"de Haan","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib150","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1023\/A:1018936806278","article-title":"Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration","volume":"10","author":"Aramaki","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib151","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000024305","article-title":"Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract","volume":"121","author":"Yoshikawa","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib152","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/viro.2000.0605","article-title":"Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity","volume":"277","author":"Cusi","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.addr.2008.09.005_bib153","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1016\/j.vaccine.2003.10.054","article-title":"Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine","volume":"22","author":"Lambkin","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib154","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/341028","article-title":"Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children","volume":"35","author":"Marchisio","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2008.09.005_bib155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00431-003-1324-6","article-title":"An update on the prevention of influenza in children and adolescents","volume":"162","author":"Heininger","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.addr.2008.09.005_bib156","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1086\/386330","article-title":"Intranasal influenza vaccine in a working population","volume":"38","author":"Sendi","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2008.09.005_bib157","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0264-410X(99)00315-1","article-title":"Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside gm1 associated to cholera toxin B enhances mucosal immune responses","volume":"18","author":"Lian","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib158","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4049\/jimmunol.167.3.1406","article-title":"Sendai virus fusion protein mediates simultaneous induction of MHC class I\/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system","volume":"167","author":"Kunisawa","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2008.09.005_bib159","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1023\/A:1007504124603","article-title":"Proofs of the structure of lipid coated nanoparticles (SMBV (TM)) used as drug carriers","volume":"17","author":"De Miguel","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0005-2736(97)00041-2","article-title":"Characterization and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles","volume":"1327","author":"Major","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2008.09.005_bib161","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1097-0282(19970415)41:5<511::AID-BIP3>3.0.CO;2-P","article-title":"Structural characterization (shape and dimensions) and stability of polysaccharide\/lipid nanoparticles","volume":"41","author":"Santos","year":"1997","journal-title":"Biopolymers"},{"key":"10.1016\/j.addr.2008.09.005_bib162","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(01)00175-2","article-title":"Synthetic biomimetic supra molecular biovector (TM) (SMBV (TM)) particles for nasal vaccine delivery","volume":"51","author":"von Hoegen","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib163","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0378-5173(02)00227-2","article-title":"Development of a new method to characterize (SMBV (TM)) antigen formulations using surface plasmon resonance technology","volume":"242","author":"Siguier","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2008.09.005_bib164","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0264-410X(96)00043-6","article-title":"A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens","volume":"14","author":"Castignolles","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib165","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/0264-410X(94)90150-3","article-title":"Stabilization and enhancement of interleukin-2 in-vitro bioactivity by new carriers \u2014 supramolecular biovectors","volume":"12","author":"Castignolles","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib166","series-title":"Proceed. Intl. Symp. Control. Rel. Bioact. Mater., Vol. 25","first-page":"643","article-title":"Biovector loaded with a trivalent split influenza vaccien administered intranasally induce a strong mucosal and serosal immune response in mice","author":"Major","year":"1998"},{"key":"10.1016\/j.addr.2008.09.005_bib167","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00006231-199902000-00010","article-title":"Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine","volume":"20","author":"Bryant","year":"1999","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.addr.2008.09.005_bib168","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3565(24)35204-8","article-title":"Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier","volume":"291","author":"Fenart","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2008.09.005_bib169","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0264-410X(95)00233-Q","article-title":"Combination of human cytomegalovirus recombinant immediate-early protein (ie1) with 80\u00a0nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ t-cell clones in vitro","volume":"14","author":"Prieur","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib170","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/S0264-410X(02)00191-3","article-title":"Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and ctl responses","volume":"20","author":"Debin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib171","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4161\/hv.1.1.1553","article-title":"Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults","volume":"1","author":"Halperin","year":"2005","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.addr.2008.09.005_bib172","first-page":"400","article-title":"A retrospective review of lesions associated with the use of Freund's adjuvant","volume":"39","author":"Broderson","year":"1989","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib173","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.1088949","article-title":"Islet regeneration during the reversal of autoimmune diabetes in nod mice","volume":"302","author":"Kodama","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.09.005_bib174","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1208\/aapsj070357","article-title":"Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs","volume":"7","author":"Alcon","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2008.09.005_bib175","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1016\/j.vaccine.2005.08.015","article-title":"A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations","volume":"24","author":"Hinkula","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib176","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1016\/j.vaccine.2008.03.066","article-title":"Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses","volume":"26","author":"Brave","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib177","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2005.07.053","article-title":"Lipid microparticles for mucosal immunization against hepatitis B","volume":"24","author":"Saraf","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib178","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0264-410X(98)00408-3","article-title":"Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride\/fatty acid lipid suspensions as adjuvants","volume":"17","author":"Schroder","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib179","series-title":"Proceed. EUFEPS Workshop on Opportunity and Challenges in Vaccine Delivery, 14","first-page":"35","article-title":"Polysaccharide-based nanocarriers for intranasal vaccination: application to rHBsAg","author":"Vicente","year":"2008"},{"key":"10.1016\/j.addr.2008.09.005_bib180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/B:PHAM.0000022414.17183.58","article-title":"Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery","volume":"21","author":"Nagamoto","year":"2004","journal-title":"Pharm. Res."},{"issue":"Suppl 40","key":"10.1016\/j.addr.2008.09.005_bib181","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijmm.2006.02.002","article-title":"Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge","volume":"296","author":"Goncharova","year":"2006","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.addr.2008.09.005_bib182","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2006.09.010","article-title":"Particulate nanomedicines","volume":"58","author":"Moghimi","year":"2006","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib183","first-page":"51","article-title":"Polymer-coated lipid nanostructures as carriers for oral peptide delivery","volume":"97","author":"Garcia-Fuentes","year":"2004","journal-title":"Bull. Tech. Gattefoss\u00e9"},{"key":"10.1016\/j.addr.2008.09.005_bib184","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejps.2005.02.008","article-title":"A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery","volume":"25","author":"Garcia-Fuentes","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","article-title":"Transmucosal macromolecular drug delivery","volume":"101","author":"Prego","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib186","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","article-title":"PLGA nanoparticles in drug delivery: the state of the art","volume":"21","author":"Bala","year":"2004","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.addr.2008.09.005_bib187","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.addr.2004.09.002","article-title":"Formulation aspects of biodegradable polymeric microspheres for antigen delivery","volume":"57","author":"Tamber","year":"2005","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib188","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0169-409X(03)00037-1","article-title":"Polyhydroxyalkanonate derivatives in current clinical applications and trials","volume":"55","author":"Ueda","year":"2003","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib189","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0264-410X(93)90241-O","article-title":"Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems","volume":"11","author":"Aguado","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib190","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1023\/A:1020452531828","article-title":"Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro","volume":"19","author":"Lutsiak","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib191","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbm.10019","article-title":"Uptake of poly(d,l-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo","volume":"60","author":"Newman","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib192","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/3469","article-title":"Fully mobilizing host defense: building better vaccines","volume":"16","author":"Raychaudhuri","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2008.09.005_bib193","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.2042-7158.1993.tb05532.x","article-title":"Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(l-lactic acid) microspheres in rats, rabbits and guinea-pigs","volume":"45","author":"Almeida","year":"1993","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2008.09.005_bib194","series-title":"Proceed. Intl. Symp. Control. Rel. Bioact. Mater., Vol. 25","first-page":"645","article-title":"Biodegradable nanoparticles in nasal vaccine delivery: effect of particle size and loading","author":"Somavarapu","year":"1998"},{"key":"10.1016\/j.addr.2008.09.005_bib195","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1163\/156856299X00892","article-title":"Intranasal immunization against influenza virus using polymeric particles","volume":"10","author":"Lemoine","year":"1999","journal-title":"J. Biomater. Sci., Polym. Ed."},{"key":"10.1016\/j.addr.2008.09.005_bib196","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0927-7765(99)00157-5","article-title":"The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration","volume":"18","author":"Tobio","year":"2000","journal-title":"Colloids Surf., B Biointerfaces"},{"key":"10.1016\/j.addr.2008.09.005_bib197","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.09.005_bib198","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/0894268041457183","article-title":"Peg-pla nanoparticles as carriers for nasal vaccine delivery","volume":"17","author":"Vila","year":"2004","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.addr.2008.09.005_bib199","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"Pla-peg particles as nasal protein carriers: the influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2008.09.005_bib200","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1023\/A:1011063232257","article-title":"Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice","volume":"18","author":"Jung","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib201","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pat.280","article-title":"Pla-peg nanospheres: new carriers for transmucosal delivery of proteins and plasmid DNA","volume":"13","author":"Vila","year":"2002","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.addr.2008.09.005_bib202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1023\/A:1007582911958","article-title":"Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres","volume":"17","author":"Fu","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib203","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1163\/1568562041753098","article-title":"Design and characterisation of new nanoparticulate polymer blends for drug delivery","volume":"15","author":"Csaba","year":"2004","journal-title":"J. Biomater. Sci., Polym. Ed."},{"key":"10.1016\/j.addr.2008.09.005_bib204","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0928-0987(03)00019-8","article-title":"Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha","volume":"18","author":"Sanchez","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1021\/bm049577p","article-title":"PLGA: Poloxamer and PLGA:Poloxamine blend nanoparticles: new carriers for gene delivery","volume":"6","author":"Csaba","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2008.09.005_bib206","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2006.03.017","article-title":"PLGA:Poloxamer and PLGA:Poloxamine blend nanostructures as carriers for nasal gene delivery","volume":"113","author":"Csaba","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0168-3659(99)00134-0","article-title":"Branched biodegradable polyesters for parenteral drug delivery systems","volume":"64","author":"Breitenbach","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib208","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2004.09.003","article-title":"The role of branched polyesters and their modifications in the development of modern drug delivery vehicles","volume":"101","author":"Dailey","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib209","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddtec.2005.05.008","article-title":"Chitosan and the mucosal delivery of biotechnology drugs","volume":"2","author":"Issa","year":"2005","journal-title":"Drug Discov. Today: Technologies"},{"key":"10.1016\/j.addr.2008.09.005_bib211","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","article-title":"The basics and underlying mechanisms of mucoadhesion","volume":"57","author":"Smart","year":"2005","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib212","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.addr.2003.10.018","article-title":"M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery","volume":"56","author":"Jepson","year":"2004","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib213","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc970045y","article-title":"Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres","volume":"9","author":"Akashi","year":"1998","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2008.09.005_bib214","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jmv.20317","article-title":"Induction of dendritic cell-mediated immune responses against HIV-1 by antigen-capturing nanospheres in mice","volume":"76","author":"Kawamura","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2008.09.005_bib215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jmv.20100","article-title":"Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques","volume":"73","author":"Miyake","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2008.09.005_bib216","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/bm050657i","article-title":"Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(gamma-glutamic acid)-graft-l-phenylalanine copolymers","volume":"7","author":"Akagi","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2008.09.005_bib217","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1163\/156856206777996871","article-title":"Multifunctional conjugation of proteins on\/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid)","volume":"17","author":"Akagi","year":"2006","journal-title":"J. Biomater. Sci., Polym. Ed."},{"key":"10.1016\/j.addr.2008.09.005_bib218","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1016\/j.polymer.2007.08.038","article-title":"Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: potential applications","volume":"48","author":"Akagi","year":"2007","journal-title":"Polymer"},{"key":"10.1016\/j.addr.2008.09.005_bib219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.12.026","article-title":"Chitosan microspheres as a potential carrier for drugs","volume":"274","author":"Sinha","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2008.09.005_bib220","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/IAI.68.10.5764-5770.2000","article-title":"Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens","volume":"68","author":"Bacon","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2008.09.005_bib221","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.vaccine.2003.11.011","article-title":"Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein d of bovine herpesvirus 1","volume":"22","author":"Gogev","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib222","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0264-410X(98)00077-2","article-title":"Stimulation of mucosal and systemic antibody responses against bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice","volume":"16","author":"Jabbal-Gill","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib223","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0264-410X(01)00423-6","article-title":"Projuvant (Pluronic F127\/chitosan) enhances the immune response to intranasally administered tetanus toxoid","volume":"20","author":"Westerink","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib224","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2007.05.025","article-title":"Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration","volume":"121","author":"Boonyo","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib225","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1016\/j.vaccine.2005.04.021","article-title":"Effective nasal influenza vaccine delivery using chitosan","volume":"23","author":"Read","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib226","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/10430340260185058","article-title":"Intranasal gene transfer by chitosan-DNA nanospheres protects BALB\/c mice against acute respiratory syncytial virus infection","volume":"13","author":"Kumar","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2008.09.005_bib227","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0264-410X(02)00662-X","article-title":"Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB\/c mice","volume":"21","author":"Iqbal","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib228","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1016\/j.vaccine.2004.03.033","article-title":"Intranasal delivery of chitosan-DNA vaccine generates mucosal sIgA and anti-cvb3 protection","volume":"22","author":"Xu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib229","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2007.11.027","article-title":"Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B","volume":"354","author":"Khatri","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2008.09.005_bib230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0939-6411(03)00157-7","article-title":"Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation","volume":"57","author":"Roldo","year":"2004","journal-title":"Eur. J. Pharm. Biopharm. Biopharm."},{"key":"10.1016\/j.addr.2008.09.005_bib231","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11095-006-9136-9","article-title":"Thiolated chitosan\/DNA nanocomplexes exhibit enhanced and sustained gene delivery","volume":"24","author":"Lee","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib232","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1023\/A:1012128907225","article-title":"Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines","volume":"14","author":"Calvo","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib233","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1023\/A:1018908705446","article-title":"Enhancement of nasal absorption of insulin using chitosan nanoparticles","volume":"16","author":"Fernandez-Urrusuno","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.09.005_bib234","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","article-title":"Polysaccharide colloidal particles as delivery systems for macromolecules","volume":"47","author":"Janes","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.addr.2008.09.005_bib235","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/app.12016","article-title":"Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization","volume":"12","author":"Janes","year":"2003","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib236","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2003.09.006","article-title":"Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice","volume":"57","author":"Vila","year":"2004","journal-title":"Eur. J. Pharm. Biopharm. Biopharm."},{"key":"10.1016\/j.addr.2008.09.005_bib237","doi-asserted-by":"crossref","first-page":"075105","DOI":"10.1088\/0957-4484\/19\/7\/075105","article-title":"Design of novel polysaccharidic nanostructures for gene delivery","volume":"19","author":"de la Fuente","year":"2008","journal-title":"Nanotechnology"},{"key":"10.1016\/j.addr.2008.09.005_bib238","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejpb.2005.12.006","article-title":"A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin","volume":"63","author":"Maestrelli","year":"2006","journal-title":"Eur. J. Pharm. Biopharm. Biopharm."},{"key":"10.1016\/j.addr.2008.09.005_bib239","doi-asserted-by":"crossref","first-page":"185101","DOI":"10.1088\/0957-4484\/19\/18\/185101","article-title":"Novel drug nanocarriers combining hydropilic cyclodextrins and chitosan","volume":"19","author":"Trapani","year":"2008","journal-title":"Nanotechnology"},{"key":"10.1016\/j.addr.2008.09.005_bib240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2005.11.014","article-title":"Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system","volume":"111","author":"Amidi","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2008.09.005_bib241","first-page":"54","article-title":"Chitosan nanoparticles for the delivery of plasmid DNA: preparation and characterisation","volume":"23","author":"Csaba","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib242","unstructured":"N. Csaba, M. Koping-Hoggard, E. Fernandez-Megia, R. Novoa-Carballal, R. Riguera, M.J. Alonso, Ionically crosslinked chitosan nanoparticles as gene delivery systems: Effect of pegylation degree on in vitro and in vivo gene transfer, J. Biomed. Nanotech. in press."},{"key":"10.1016\/j.addr.2008.09.005_bib243","series-title":"Proceed. 3rd World Conference on Drug Absorption, Transport and Delivery- Clinical Significance and Delivery, EUFEPS","first-page":"94","article-title":"Chitosan and chitosan-PEG nanoparticles: new carriers for nasal vaccine delivery","author":"Rezaei Mokarram","year":"2005"},{"key":"10.1016\/j.addr.2008.09.005_bib244","first-page":"429","article-title":"Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration","volume":"9","author":"Fernandez-Urrusuno","year":"1999","journal-title":"STP Pharma Sci."},{"key":"10.1016\/j.addr.2008.09.005_bib245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5173(01)00914-0","article-title":"Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia","volume":"232","author":"Hamman","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2008.09.005_bib246","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2006.06.086","article-title":"N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model","volume":"25","author":"Amidi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2008.09.005_bib247","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2008.06.029","article-title":"Mono-n-carboxymethyl chitosan (MCC) and n-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery","volume":"363","author":"Sayin","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2008.09.005_bib248","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2007.03.005","article-title":"Chitosan\/cyclodextrin nanoparticles as macromolecular drug delivery systems","volume":"340","author":"Krauland","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2008.09.005_bib249","article-title":"Chitosan\/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro","author":"Teijeiro-Osorio","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2008.09.005_bib250","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejpb.2008.01.019","article-title":"Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles","volume":"69","author":"Borges","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X08002640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X08002640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:11:47Z","timestamp":1738818707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X08002640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":250,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0169409X08002640"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2008.09.005","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}